Joan B Heijns Maria E L van der Burg Teun van Gelder Marien W J A Fieren Peter de Bruijn Ate van der Gaast Walter J Loos
10.1007/s00280-007-0671-9
Cancer Chemother Pharmacol
2008 Oct;62(5):841-7.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/18204842/
Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics Antineoplastic Combined Chemotherapy Protocols / therapeutic use Ovarian Neoplasms / drug therapy Peritoneal Dialysis, Continuous Ambulatory
Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics Antineoplastic Combined Chemotherapy Protocols / therapeutic use Ovarian Neoplasms / drug therapy Peritoneal Dialysis, Continuous Ambulatory Case Reports Antineoplastic Agents / administration & dosage Antineoplastic Agents, Phytogenic / administration & dosage Area Under Curve Carboplatin / administration & dosage Female Humans Middle Aged Neoplasm Recurrence, Local / drug therapy Paclitaxel / administration & dosage Renal Insufficiency / complications Renal Insufficiency / therapy Treatment Outcome Antineoplastic Agents Antineoplastic Agents, Phytogenic Carboplatin Paclitaxel
PMC2516550
18204842
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
2008